Novartis Ag (NVS) Cash & Current Investments (2009 - 2026)
Novartis Ag's Cash & Current Investments was $9.92 billion in Q2 2026, up 13.7% from $8.73 billion a year earlier and up 7.7% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Novartis Ag came in at $13.78 billion, up 2.3% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $13.47 billion in FY2024 (-15.8%), $16 billion in FY2023 (+61.2%), $9.93 billion in FY2022 (-65.0%) and $28.33 billion in FY2021 (+125.6%).
- Quarterly Cash & Current Investments has moved between $6.04 billion (Q2 2022) and $28.33 billion (Q4 2021) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with an average decline of 6.4% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2022 (growth of 145.9%); the worst was Q4 2022 (a decline of 65.0%).
- Per Business Quant data, NVS's Cash & Current Investments in the three quarters before Q2 2026 was $9.21 billion (Q1 2026), $13.78 billion (Q4 2025) and $11.62 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 7.85 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.69 Bn |
| Mar 31, 2026 | 6.98 Bn |
| Dec 31, 2025 | 11.59 Bn |
| Sep 30, 2025 | 9.75 Bn |
| Jun 30, 2025 | 7.00 Bn |
| Mar 31, 2025 | 7.20 Bn |
| Dec 31, 2024 | 13.46 Bn |
| Sep 30, 2024 | 14.02 Bn |
| Jun 30, 2024 | 8.44 Bn |
| Mar 31, 2024 | 9.69 Bn |
| Dec 31, 2023 | 14.43 Bn |
| Sep 30, 2023 | 12.70 Bn |
| Jun 30, 2023 | 11.17 Bn |
| Mar 31, 2023 | 12.26 Bn |
| Dec 31, 2022 | 18.93 Bn |
| Sep 30, 2022 | 19.10 Bn |
| Jun 30, 2022 | 19.76 Bn |
| Mar 31, 2022 | 18.81 Bn |
| Dec 31, 2021 | 28.33 Bn |
| Sep 30, 2021 | 8.16 Bn |
API Access
Novartis Ag Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();